リウマチ性関節炎 (Rheumatoid arthritis) とは,関節のリウマチ性関節炎 (Rheumatoid arthritis) とは,関節のリウマチ性関節炎 (Rheumatoid arthritis)
Lars Klareskog1, Anca Irinel Catrina, Stephen Paget
1Rheumatology Unit, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Lancet (London, England)
|January 23, 2009
まとめ
免疫系を標的とする革新的な生物学的薬剤は,リウマチ性関節炎 (RA) 治療を変革し,患者の治療結果を改善しました. 遺伝的および環境的要因に関するさらなる研究は,パーソナライズされた治療と病気の予防を可能にすることができます.
科学分野:
- 免疫学 免疫学とは
- レウマトロジーの病理学
- 分子病原菌の発生について
背景:
- リウマチ性関節炎 (RA) は,全身性,炎症性,自己免疫性疾患である.
- 分子病原性を理解することは,標的治療の開発に不可欠です.
研究 の 目的:
- リウマチ性関節炎に対する生物学的薬剤の進歩を強調する.
- RAの病原性における環境要因と遺伝的感受性の役割について議論する.
- 関節の炎症と破壊を管理するための新しい治療戦略を探求する.
主な方法:
- リウマチ性関節炎における分子病原性のレビュー.
- 感受性遺伝子との環境要因の相互作用の分析.
- 疾患プロセスと関節炎の分子病理学の縦断的な研究.
主要な成果:
- 特定の免疫経路を標的とする生物学的薬剤は,RAの経過と患者のアウトカムを著しく変えました.
- 遺伝子と環境の相互作用に関する新しい洞察は,主要なRAサブセットにおける病原性を明らかにします.
- 病気を修正する薬剤の早期使用を含む現在の治療戦略は,ほとんどの関節破壊を止めることができますが,すべての炎症や併発症を止めることはできません.
結論:
- RAの病原性の理解が深まったことで,効果的な生物学的治療法が開発されました.
- RAサブセットの原因と病原性を特定することは,パーソナライズされた医療と潜在的な予防の鍵です.
- 継続的な研究は,リウマチ性関節炎とその関連疾患の管理におけるさらなる改善を約束しています.
関連する概念動画
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...